ACM Research's flat ROCE and increased capital employed suggest it's not investing in high return ventures. Despite this, market optimism remains due to significant past stock returns. However, current trends don't promise high future returns.
Despite EPS growth outpacing share price increase, market enthusiasm for the stock seems muted. The company's recent 62% total shareholder return, higher than the 39% annualized return over half a decade, hints at business momentum.
ACM Research's future profit outlook isn't fully reflected in the current share price, indicating it's not too late to buy ACMR. Investors should also consider other factors like the strength of its balance sheet.
ACM Research's P/E ratio is not growing despite strong performance, possibly indicating expectations of deteriorating earnings. Predicted growth lower than market's may present a risk. Holders may face disappointment if P/E aligns with growth outlook.
Market sentiment toward the stock grows cautious. Positive buzz around the company hints at potential business momentum. However, there are notable warning signs in investment analysis.
ACM Research股票討論區
2017年上市,主要做晶元清洗設備業務,97%的市場在中國內地,當前價格32.71。
5年來營收持續增長,平均增速49.4%,營業利潤平均增速71.4%,淨利潤平均增速71.3%。2022年起利息費用轉爲利息收入,沒有利息負擔。毛利率近5年從47.1%提升到49.5%,淨資產收益率從25.2%下降到5.8%,2023年重新提升到10.7%。
5年來資產負債率從55.3%下降到37.9%,應收和存貨的比例和增速很不正常。
存貨近3年每年增加1.5億左右,但是近3年淨利潤從0.43億提高到0.97億,沒有一年超過1億,目前5.5億存貨幾乎相當於2023年5.6億的營收。
應收款項近3年累計增長2.6億,而近3年淨利僅有1.9億,這點從近3年現金流經營淨額大幅淨流出也能看出。
這兩個數據足以說明公司運營有很大問題,暫時缺乏投資價值。
Here is the first major support level I was talking about.
$應用材料(AMAT.US)$
$ACM Research(ACMR.US)$$GlobalFoundries(GFS.US)$$AXT Inc(AXTI.US)$$iShares費城交易所半導體ETF(SOXX.US)$$3倍做多半導體ETF-Direxion(SOXL.US)$$3倍做空半導體ETF-Direxion(SOXS.US)$$INVESCO PHLX SEMICONDUCTOR ETF(SOXQ.US)$
Entry price ?
暫無評論